Want to join the conversation?
$DVA 2Q15 Call: G&A in our dialysis business was down from Q1 by about $2 per treatment, driven by seasonal declines in payroll taxes and then more treatment days in the quarter and also higher levels of legal and consulting spend that occurred in the first quarter.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.